In the article on how HGF induces gefitinib resistance in the November 15, 2008 issue of Cancer Research (1), the data for post-gefitinib for patients 4, 5, and 6 are out of position in Table 1. “Y”, “N”, and “Low” should be under “T790M”, “MET amplification”, and “HGF”, respectively, for all three patients, and “1+”, “3+”, and “2+” should be under “MET” for patients 4, 5, and 6, respectively.

1
Yano S, Wang W, Li Q, Matsumoto K, Sakurama H, Nakamura T, Ogino H, Kakiuchi S, Hanibuchi M, Nishioka Y, Uehara H, Mitsudomi T, Yatabe Y, Nakamura T, Sone S. Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor–activating mutations.
Cancer Res
 
2008
;
68
:
9479
–87.
View Original Article
©2009 American Association for Cancer Research.
2009